Anthony Defino

KIAWAH ISLAND, S.C. — Povicaine, launched in late 2024, has “become a staple in our practice,” Brandon D. Ayres, MD, said in this Healio Video Perspective from Kiawah Eye.

FORT LAUDERDALE, Fla. — Home OCT offers personalized insights on treatment response for wet age-related macular degeneration that may help reduce treatment burden, according to a speaker.While second-generation anti-VEGF agents allow for extended dosing intervals longer than what is on label for many patients, not all patients can be extended, Judy E. Kim, MD, FARVO, FASRS, said at the

KIAWAH ISLAND, S.C. — Ophthalmologists and patients should consider alternatives to surgical intervention for eyelid skin rejuvenation, Gene R. Howard, MPH, MD, said in this Healio Video Perspective from Kiawah Eye.

KIAWAH ISLAND, S.C. — Consider using an artificial iris implant in patients with congenital or acquired aniridia, Karolinne M. Rocha, MD, PhD, told Healio at Kiawah Eye.An implant allows ophthalmologists to perform certain suture techniques in cases in which this normally would not be possible. Rocha overviewed the types of devices and reviewed surgical techniques.

SALT LAKE CITY — In this Healio Video Perspective from the ARVO meeting, SriniVas R. Sadda, MD, FARVO, discusses a long-term study evaluating MCO-010 for the treatment of retinitis pigmentosa.

LONG BEACH, Calif. — Re-Vana Therapeutics is collaborating with Boehringer Ingelheim to develop extended-release therapies for ophthalmic diseases, according to a press release.At the American Society of Retina Specialists annual meeting, Re-Vana CEO Michael O’Rourke told Healio that the relationship will include up to three target-specific therapeutics from Boehringer Ingelheim to

LAS VEGAS — Topcon Healthcare announced a strategic investment in Senseye, which is developing the first mental health diagnostic platform powered by ocular biomarkers, according to a company press release. The technology is designed to utilize AI and computer vision to help diagnose and monitor conditions including PTSD, major depressive disorder and generalized anxiety disorder through

LAS VEGAS — ICare USA launched the iCare Altius, a cloud-based imaging platform designed to offer eye care providers instant access to diagnostic images and patient data, according to a company press release.“Altius is designed to increase the operational efficiency of a practice utilizing iCare imaging devices by providing HIPAA-compliant review of image data from anywhere via the

Harrow entered into an agreement to acquire Melt Pharmaceuticals and plans to submit a new drug application for MELT-300, Melt’s lead candidate, to the FDA in 2027. “MELT-300 integrates seamlessly into Harrow’s existing commercial infrastructure, specifically our surgical team, which calls on and has established relationships with ophthalmologists,” Mark L. Baum, CEO of Harrow, told Healio. “The

ORLANDO — Ocular pain can have many causes and should not always be diagnosed as dry eye disease, according to a speaker here at Cornea Subspecialty Day at the American Academy of Ophthalmology meeting. According to Anat Galor, MD, MSPH, pain starts with nociceptive signals and is dependent on peripheral nerves, central nerves and autonomic nerves.